Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2003
10/14/2003US6632438 Vaccines
10/14/2003CA2367107C Methods for limiting scar and adhesion formation
10/14/2003CA2223505C Anti-fungal and anti-bacterial histatin-based peptides
10/14/2003CA2165828C Peptidase resistant thrombin receptor peptide ligand
10/09/2003WO2003083436A2 Fibrinogen binding moieties
10/09/2003WO2003082924A1 Immunotherapeutic and immunoprophylactic reagents
10/09/2003WO2003082923A1 Process for crosslinking polypeptides
10/09/2003WO2003082905A1 Plant retroviral polynucleotides and methods for use thereof
10/09/2003WO2003082898A2 Novel analogues of glucose-dependent insulinotropic polypeptide
10/09/2003WO2003082802A1 Acid and ester compounds and methods of using the same
10/09/2003WO2003082317A1 Peptide epitopes recognized by antigen specific cd8+ t lymphocytes
10/09/2003WO2003082268A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/09/2003WO2003082197A2 Immunosuppressant compounds, methods and uses related thereto
10/09/2003WO2003030927A3 Use of thymulin-like peptides for making pain-relieving medicines
10/09/2003WO2003020750A3 Antigen mimotopes and vaccine against cancers
10/09/2003WO2003014076A3 Bi-directional synthesis of oligoguanidine transport agents
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003US20030191278 Of given amino acid sequence; use as thrombolytic drugs and vasodilators
10/09/2003US20030191057 Cardiovascular disorders; antiinflammatory agents
10/09/2003US20030191049 Oligomers of nonpeptide restricted mimetics of dipeptides of tripeptides, and the use thereof in the synthesis of synthetic proteins and polypeptides
10/09/2003US20030190740 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment
10/09/2003US20030190705 Method of humanizing immune system molecules
10/09/2003US20030190328 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
10/09/2003CA2479939A1 Immunosuppressant compounds, methods and uses related thereto
10/09/2003CA2479764A1 Hemiasterlin derivatives and uses thereof
10/09/2003CA2479750A1 Fibrinogen binding moieties
10/08/2003EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor
10/08/2003EP1350428A1 Portable, motor-powered shears
10/08/2003EP1350106A2 Ultra-sensitive detection systems
10/08/2003EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same
10/08/2003EP0551460B2 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV)
10/08/2003CN1447818A Anti-heparin peptides
10/08/2003CN1447817A Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts
10/08/2003CN1447699A Peptide and peptide minetic conjugates with integrin-inhibitor properties
10/08/2003CN1446821A Active antibiotics dodeca peptide
10/08/2003CN1123360C Inhibitors of cyclophilin rotamase activity
10/07/2003US6630573 Tau-conotoxin peptides
10/07/2003US6630570 Of tumor cells and tissues; derived from vaso-active intestinal protein, somatostatin or neurotensin; methine/cyanine; useful for endoscopy
10/07/2003US6630513 Capable of lowering plasma cholesterol levels and inhibiting abnormal cell proliferation, such as in cervical adenocarcinoma
10/07/2003US6630450 Method of treating dyslipidemia
10/07/2003US6630447 Therapy for hematopoietic neoplasma
10/07/2003US6630351 Transfecting a cell by attaching a reversible labile membrane activity inhibitor to a melittin peptide; adding peptide to solution containing the nucleic acid; endocytosis
10/07/2003US6630308 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
10/07/2003US6630147 Pseudomycin natural products
10/07/2003US6630146 Candida albicans phosphomannan complex as a vaccine
10/07/2003CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2
10/02/2003WO2003081510A1 Method and system to build optimal models of 3-dimensional molecular structures
10/02/2003WO2003080662A1 Protein kinase c modulators, their aminoacid and nucleotide sequences and uses thereof
10/02/2003WO2003080659A1 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
10/02/2003WO2003080652A1 Antimicrobial peptide, its analogs and antimicrobial composition comprising them
10/02/2003WO2003080544A1 Radiofluorination methods
10/02/2003WO2003080102A1 Method of stimulating growth and resistance to diseases of aquatic organisms
10/02/2003WO2003051910A3 Inhibitors of hepatitis c virus protease
10/02/2003WO2003050139A3 Prion inhibiting peptides and derivatives thereof
10/02/2003WO2003010199A3 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
10/02/2003WO2003006604A3 Cyclic peptides as potent and selective melanocortin-4 receptor agonists
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002020570A3 Mitochondrial membrane permeabilization bv hiv-1 vpr and methods of screening
10/02/2003US20030187585 Method and system to build optimal models of 3-dimensional molecular structures
10/02/2003US20030187186 Glycopeptide and preparation thereof
10/02/2003US20030186891 Polypeptide comprising fragments of matrix extracellular phosphoglycoproteins used to control calcitriol concentrations in cells, for prophylaxis of bone disorders
10/02/2003US20030186890 Amphipathic linear peptides and formulations containing said peptides
10/02/2003US20030186888 Diastereo analog of peptide SPFK-amide with selective anti-microbial activity and a method thereof
10/02/2003US20030186877 Helical peptidomimetics
10/02/2003US20030186863 For production of peptidomimetic drugs that modulate a large class of proteins involved in signal transduction pathways and oncogenesis
10/02/2003US20030186857 Use of 3-position cyclosporin derivatives for hair growth
10/02/2003US20030186856 Process for the isolation of pharmaceutical compound cyclosporin a from fungus fusarium nivale
10/02/2003US20030186855 Systemically administering cyclic peptide compound, salt, ester or prodrug for reducing toxicity associated with the administration of cyclosporin A
10/02/2003US20030186854 Having low hemolytic activity, antiparasitic, antifungal and antibacterial activities
10/02/2003US20030186852 Compositions and methods for controlling plant pests
10/02/2003US20030186844 Gherlin analogs
10/02/2003US20030186406 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186225 Comprises DNA sequences coding viral protein for use in developing vaccine which prevents porcine reproductive and respiratory syndrome viral infections
10/02/2003US20030186214 Peptide conjugates and fluorescence detection methods for intracellular caspase assay
10/02/2003US20030185890 Compositions and methods for polynucleotide delivery
10/02/2003US20030185870 Oligopeptide binding agent including a first ligand that specifically binds a non-biological substrate and a second ligand that specifically binds a biological substrate.
10/02/2003US20030185862 Fusion peptide of human type- I collagen derived peptide and Tat peptide, preparation therof, and skin anti-aging cosmetic composition comprising the same
10/02/2003US20030185843 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185842 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185840 Induction of tumor immunity by variants of folate binding protein
10/02/2003US20030185793 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same
10/02/2003US20030185791 TNF-derived peptides for use in treating oedema
10/02/2003US20030185756 Carbocyanine dye for visualization, photosensitizer for photodynamic treatment, and tumor receptor-avid peptide for site-specific delivery of the probe and phototoxic agent to diseased tissues
10/02/2003CA2480388A1 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
10/01/2003EP1348460A2 Creating an aerosolized formulation of insulin
10/01/2003EP1348026A2 Fibrin binding moieties useful as imaging agents
10/01/2003EP1348024A2 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
10/01/2003EP1347991A2 Amphipathic peptides and their use for transferring substances of interest into cells
10/01/2003EP1347953A2 Agents and methods for promoting bone growth
10/01/2003EP1347784A2 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
10/01/2003EP1347783A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units
10/01/2003EP0946589B1 Inhibitors of peptide binding to mhc class ii proteins
10/01/2003EP0863917B1 Targeted cytotoxic anthracycline analogs
10/01/2003EP0783511B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446230A Peptide and peptide mimetic derivatives with integrin inhibitor preperties Ôàí"
10/01/2003CN1446229A Somatostatin analogues
10/01/2003CN1446201A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/01/2003CN1446094A Method for obtaining antigenic structures enhancing specific cross reactivity
1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 423